perfluoropentane has been researched along with Disease Models, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, CH; Ho, YJ; Kang, ST; Lee, YH; Wang, CH; Yeh, CK | 1 |
| Bonanno, AM; Graham, TL; Madtson, BM; Ross, JD; Wilson, LN | 1 |
| Ding, X; Gao, X; Luo, J; Luo, Y; Pu, D; Wang, Q; Xu, D; Yan, S; Yong, L; Zhang, Y; Zou, J | 1 |
| Borrelli, MJ; Brown, AT; Culp, WC; Lay, JO; Lowery, JD; Ricca, AM; Skinner, RD; Woods, SD | 1 |
| Larson, DF; Strom, J; Swyer, TW | 1 |
| Arthur, MC; Borrelli, MJ; Brown, AT; Culp, WC; Fitzgerald, RT; Nix, JS; Ou, X; Skinner, RD | 1 |
| Mahon, RT; Regis, DP; Sheppard, RL | 1 |
| Arthur, MC; Brown, AT; Culp, WC; Lowery, JD; Roberson, PK; Skinner, RD | 1 |
| Bergoe, GW; Lundgren, CE; Olszowka, AJ; Tyssebotn, IM | 1 |
| Borrelli, MJ; Brown, AT; Culp, WC; Hennings, LJ; Johnson, JL; Lowery, JD; Roberson, PK; Skinner, RD; Unger, EC; Woods, SD | 1 |
| Burns, PN; Cherin, E; Foster, FS; Gorelikov, I; Lee, M; Matsuura, N; Reznik, N; Williams, R; Wright, C | 1 |
| Erickson, JM; Escobar, J; Grayburn, PA; Velasco, CE; Womack, L | 1 |
| Bickler, PE; Eger, EI; Taylor, DM | 1 |
13 other study(ies) available for perfluoropentane and Disease Models, Animal
| Article | Year |
|---|---|
Macrophages as Drug Delivery Carriers for Acoustic Phase-Change Droplets.
Topics: Animals; Cell Survival; Disease Models, Animal; Doxorubicin; Drug Carriers; Drug Delivery Systems; Feasibility Studies; Flow Cytometry; Fluorocarbons; Lipids; Macrophages; Mice; Phantoms, Imaging; Tumor Cells, Cultured; Ultrasonography | 2018 |
Efficacy of the perfluorocarbon dodecafluoropentane as an adjunct to pre-hospital resuscitation.
Topics: Algorithms; Animals; Blood Substitutes; Blood Transfusion; Disease Models, Animal; Emergency Medical Services; Fluid Therapy; Fluorocarbons; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Resuscitation; Sus scrofa | 2018 |
Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Breast Neoplasms; Cell Proliferation; Combined Modality Therapy; Disease Models, Animal; Female; Fluorocarbons; Hematoporphyrins; High-Intensity Focused Ultrasound Ablation; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2019 |
Progress in dodecafluoropentane emulsion as a neuroprotective agent in a rabbit stroke model.
Topics: Animals; Brain; Cerebral Infarction; Disease Models, Animal; Emulsions; Fluorocarbons; Neuroprotective Agents; Rabbits; Stroke; Time Factors | 2013 |
Nanoparticle oxygen delivery to the ischemic heart.
Topics: Animals; Blood Substitutes; Disease Models, Animal; Fluorocarbons; Male; Mice; Myocardial Ischemia; Myocardium; Nanoparticles; Oxygen | 2014 |
Dodecafluoropentane emulsion delays and reduces MRI markers of infarction in a rat stroke model: a preliminary report.
Topics: Animals; Brain Infarction; Brain Ischemia; Carotid Artery, Common; Disease Models, Animal; Emulsions; Fluorocarbons; Magnetic Resonance Imaging; Male; Middle Cerebral Artery; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke | 2015 |
Dodecafluoropentane (DDFPe) and decompression sickness-related mortality in rats.
Topics: Animals; Decompression Sickness; Disease Models, Animal; Fluorocarbons; Liver; Male; Myocardium; Rats; Rats, Sprague-Dawley; Seizures; Survival Rate | 2015 |
Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Emulsions; Female; Fibrinolytic Agents; Fluorocarbons; Infarction, Anterior Cerebral Artery; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Male; Neuroprotective Agents; Rabbits; Random Allocation; Reperfusion Injury; Single-Blind Method; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 2015 |
Hypoxia due to shunts in pig lung treated with O2 and fluorocarbon-derived intravascular microbubbles.
Topics: Animals; Arteriovenous Shunt, Surgical; Carbon Dioxide; Disease Models, Animal; Fluorocarbons; Hyperbaric Oxygenation; Hypoxia; Injections, Intravenous; Microbubbles; Oxygen; Respiration; Swine | 2010 |
Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model.
Topics: Animals; Cerebral Angiography; Cerebral Hemorrhage; Chi-Square Distribution; Disease Models, Animal; Emulsions; Fluorocarbons; Rabbits; Random Allocation; Statistics, Nonparametric; Stroke; Tissue Plasminogen Activator | 2012 |
Characterization of submicron phase-change perfluorocarbon droplets for extravascular ultrasound imaging of cancer.
Topics: Acrylic Resins; Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Fluorocarbons; Mice; Microbubbles; Neoplasms; Particle Size; Phantoms, Imaging; Ultrasonography | 2013 |
Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia.
Topics: Animals; Contrast Media; Disease Models, Animal; Dogs; Echocardiography; Fluorocarbons; Hydrocarbons, Fluorinated; Myocardial Infarction; Myocardial Ischemia; Prognosis; Risk Factors | 1995 |
Halothane, but not the nonimmobilizers perfluoropentane and 1,2-dichlorohexafluorocyclobutane, depresses synaptic transmission in hippocampal CA1 neurons in rats.
Topics: Action Potentials; Anesthetics; Anesthetics, Inhalation; Animals; Chlorofluorocarbons; Cyclobutanes; Disease Models, Animal; Evoked Potentials; Fluorocarbons; Halothane; Hippocampus; Learning; Memory; Neurons; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Reaction Time; Synapses; Synaptic Transmission | 1999 |